carnitine has been researched along with Prostatic Neoplasms in 9 studies
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the levels of serum carnitine in patients with cancer in digestive organs and to compare them with other cancers in order to provide new insights into the mechanisms of cachexia." | 7.73 | Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia. ( Barone, G; Cannizzaro, MA; Costanzo, M; Gargante, MP; Malaguarnera, M; Oreste, G; Risino, C; Tomasello, AV, 2006) |
| "Plasma acylcarnitines [(C2, C16:1, C18, C18:1, C18:1-OH, and C18:2)], glycerophospholipids (lysophosphatidylcholine-acyl, -di-acyl, and -di-acyl acyl-alkyl) and sphingomyelins [SM (OH) C16:1, SM C18:0, SM C18:1, and SM C20:2] significantly increased on PND 145, when chronic inflammation was observed in the dorsolateral prostate of rats dosed with EB, T, and E." | 3.96 | Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones. ( Beger, RD; Cao, Z; Nakamura, N; Pence, LM, 2020) |
| "Associations between pre-diagnostic levels of 120 circulating metabolites (acylcarnitines, amino acids, biogenic amines, phosphatidylcholines, sphingolipids, and hexoses) and the risks of breast, prostate, and colorectal cancer were evaluated by Cox regression analyses using data of a prospective case-cohort study including 835 incident cancer cases." | 3.83 | Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. ( Boeing, H; Floegel, A; Johnson, T; Kaaks, R; Kühn, T; Otto, W; Rolle-Kampczyk, U; Sookthai, D; von Bergen, M, 2016) |
| "To evaluate the levels of serum carnitine in patients with cancer in digestive organs and to compare them with other cancers in order to provide new insights into the mechanisms of cachexia." | 3.73 | Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia. ( Barone, G; Cannizzaro, MA; Costanzo, M; Gargante, MP; Malaguarnera, M; Oreste, G; Risino, C; Tomasello, AV, 2006) |
| "Here, we report that in prostate cancer cells (PCCs) microRNAs (miRNAs) greatly contribute to deregulation of mitochondrial fatty acid (FA) oxidation via carnitine system modulation." | 1.46 | Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences. ( Calarco, A; Calogero, RA; Crispi, S; Di Salle, A; Finicelli, M; Galderisi, U; Gentilucci, A; Margarucci, S; Peluso, G; Riccardo, F; Sciarra, A; Valentino, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Marín de Mas, I | 1 |
| Torrents, L | 1 |
| Bedia, C | 1 |
| Nielsen, LK | 1 |
| Cascante, M | 1 |
| Tauler, R | 1 |
| Zoni, E | 1 |
| Minoli, M | 1 |
| Bovet, C | 1 |
| Wehrhan, A | 1 |
| Piscuoglio, S | 1 |
| Ng, CKY | 1 |
| Gray, PC | 1 |
| Spahn, M | 1 |
| Thalmann, GN | 1 |
| Kruithof-de Julio, M | 1 |
| Crocetto, F | 1 |
| Boccellino, M | 1 |
| Barone, B | 1 |
| Di Zazzo, E | 1 |
| Sciarra, A | 2 |
| Galasso, G | 1 |
| Settembre, G | 1 |
| Quagliuolo, L | 1 |
| Imbimbo, C | 1 |
| Boffo, S | 1 |
| Angelillo, IF | 1 |
| Di Domenico, M | 1 |
| Nakamura, N | 1 |
| Pence, LM | 1 |
| Cao, Z | 1 |
| Beger, RD | 1 |
| Valentino, A | 1 |
| Calarco, A | 1 |
| Di Salle, A | 1 |
| Finicelli, M | 1 |
| Crispi, S | 1 |
| Calogero, RA | 1 |
| Riccardo, F | 1 |
| Gentilucci, A | 1 |
| Galderisi, U | 1 |
| Margarucci, S | 1 |
| Peluso, G | 1 |
| Kühn, T | 1 |
| Floegel, A | 1 |
| Sookthai, D | 1 |
| Johnson, T | 1 |
| Rolle-Kampczyk, U | 1 |
| Otto, W | 1 |
| von Bergen, M | 1 |
| Boeing, H | 1 |
| Kaaks, R | 1 |
| Zhang, F | 1 |
| Bruschweiler-Li, L | 1 |
| Robinette, SL | 1 |
| Brüschweiler, R | 1 |
| STRACK, E | 1 |
| BEMM, H | 1 |
| ROTZSCH, W | 1 |
| Malaguarnera, M | 1 |
| Risino, C | 1 |
| Gargante, MP | 1 |
| Oreste, G | 1 |
| Barone, G | 1 |
| Tomasello, AV | 1 |
| Costanzo, M | 1 |
| Cannizzaro, MA | 1 |
1 review available for carnitine and Prostatic Neoplasms
| Article | Year |
|---|---|
The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Topics: Acetylcysteine; Carnitine; Chronic Disease; Dietary Supplements; Disease Progression; Fatty Acids, U | 2020 |
8 other studies available for carnitine and Prostatic Neoplasms
| Article | Year |
|---|---|
Stoichiometric gene-to-reaction associations enhance model-driven analysis performance: Metabolic response to chronic exposure to Aldrin in prostate cancer.
Topics: Aldrin; Carnitine; Cell Line, Tumor; Computational Biology; Endocrine Disruptors; Humans; Lipidomics | 2019 |
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
Topics: Aged; Carnitine; Case-Control Studies; Chromatography, Liquid; Disease Progression; Fatty Acids; Hum | 2019 |
Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones.
Topics: Amino Acids; Animals; Biomarkers; Carnitine; Estradiol; Glycerophospholipids; Glycine; Gonadal Stero | 2020 |
Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.
Topics: Carcinogenesis; Carnitine; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Cell Proliferation; F | 2017 |
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carnitine; Cohort Studies; Colorectal Neoplasms; Female; Humans | 2016 |
Self-consistent metabolic mixture analysis by heteronuclear NMR. Application to a human cancer cell line.
Topics: Carbon Isotopes; Carnitine; Cell Line, Tumor; Glucose; Humans; Inositol; Male; Nuclear Magnetic Reso | 2008 |
[TRIMETHYLAMINE AND TRIMETHYLAMINE OXIDE IN THE URINE AFTER THE ADMINISTRATION OF N-14- AND N-15-(-) CARNITINE].
Topics: Amines; Body Fluids; Carnitine; Folic Acid; Humans; Hyperthyroidism; Male; Methylamines; Nitrogen; P | 1963 |
Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia.
Topics: Adult; Breast Neoplasms; Cachexia; Carnitine; Case-Control Studies; Diet; Disease Progression; Femal | 2006 |